For: | Grant RK, Brindle WM, Donnelly MC, McConville PM, Stroud TG, Bandieri L, Plevris JN. Gastrointestinal and liver disease in patients with schizophrenia: A narrative review. World J Gastroenterol 2022; 28(38): 5515-5529 [PMID: 36304087 DOI: 10.3748/wjg.v28.i38.5515] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i38/5515.htm |
Number | Citing Articles |
1 |
Miko Iwata, Masakazu Hatano, Kana Ito, Haruna Matsuzaki, Shigeki Yamada. Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population. Neuropsychiatric Disease and Treatment 2023; : 2061 doi: 10.2147/NDT.S425541
|
2 |
Teng-Hung Yu, Thung-Lip Lee, Chin-Feng Hsuan, Cheng-Ching Wu, Chao-Ping Wang, Yung-Chuan Lu, Ching-Ting Wei, Fu-Mei Chung, Yau-Jiunn Lee, I-Ting Tsai, Wei-Hua Tang. Inter-relationships of risk factors and pathways associated with all-cause mortality in patients with chronic schizophrenia. Frontiers in Psychiatry 2024; 14 doi: 10.3389/fpsyt.2023.1309822
|
3 |
Sitong Zhang, Qiyue Wang, Daniel En Liang Tan, Vritika Sikka, Cheng Han Ng, Yan Xian, Dan Li, Mark Muthiah, Nicholas W. S. Chew, Gert Storm, Lingjun Tong, Jiong‐Wei Wang. Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles. Journal of Extracellular Vesicles 2024; 13(6) doi: 10.1002/jev2.12466
|
4 |
Resheed Alkhiari. Psychiatric and Neurological Manifestations of Celiac Disease in Adults. Cureus 2023; doi: 10.7759/cureus.35712
|
5 |
Anwar Mulugeta, Vijayaprakash Suppiah, Elina Hyppönen. Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study. Journal of Psychiatric Research 2023; 162: 1 doi: 10.1016/j.jpsychires.2023.04.010
|
6 |
Jakub Rogalski, Karolina Czarnecka-Chrebelska, Kinga Węglewska, Kacper Płeska, Oliwia Gawlik-Kotelnicka. Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102366 doi: 10.1016/j.clinre.2024.102366
|
7 |
Francesc Casanovas, Fernando Dinamarca, Margarita Posso, Anna Mané, Sílvia Oller, David Córcoles, Francesc Macià, Maria Sala, Víctor Pérez-Sola, Ada I. Ruiz. Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis. Psychiatry Research 2024; 342: 116206 doi: 10.1016/j.psychres.2024.116206
|
8 |
Shahrzad Bazargan-Hejazi, Anaheed Shirazi, David Hampton, Deyu Pan, Daniel Askharinam, Magda Shaheen, Gul Ebrahim, Denese Shervington. Examining racial disparity in psychotic disorders related ambulatory care visits: an observational study using national ambulatory medical care survey 2010–2015. BMC Psychiatry 2023; 23(1) doi: 10.1186/s12888-023-05095-y
|
9 |
Linlin Yue, Linlin Sun, Nan Li. Psychotropic medication and hepatobiliary health: Ultrasound observations on patients with schizophrenia. The International Journal of Psychiatry in Medicine 2024; doi: 10.1177/00912174241280510
|
10 |
Sormeh Nourbakhsh, Stephen J Ferrando. Primary versus secondary psychosis in a patient with congenital liver disease. BMJ Case Reports 2024; 17(7): e259623 doi: 10.1136/bcr-2024-259623
|
11 |
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, Ana Cláudia Paiva-Santos, Patrícia C. Pires. Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy. Pharmaceutics 2023; 15(2): 678 doi: 10.3390/pharmaceutics15020678
|
12 |
Agnieszka Matuszewska, Krzysztof Kowalski, Paulina Jawień, Tomasz Tomkalski, Dagmara Gaweł-Dąbrowska, Anna Merwid-Ląd, Ewa Szeląg, Karolina Błaszczak, Benita Wiatrak, Maciej Danielewski, Janusz Piasny, Adam Szeląg. The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia. International Journal of Molecular Sciences 2023; 24(7): 6492 doi: 10.3390/ijms24076492
|
13 |
Yingying Xie, Yao Zhao, Yujing Zhou, Yurong Jiang, Yujie Zhang, Jiaojiao Du, Mengjing Cai, Jilian Fu, Huaigui Liu. Shared Genetic Architecture Among Gastrointestinal Diseases, Schizophrenia, and Brain Subcortical Volumes. Schizophrenia Bulletin 2024; 50(5): 1243 doi: 10.1093/schbul/sbae099
|
14 |
Jakub Rogalski, Oliwia Gawlik-Kotelnicka, Tomasz Tomczak. Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia. Current Problems of Psychiatry 2024; 25: 226 doi: 10.12923/2353-8627/2024-0021
|